Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure

BACKGROUND: The angiotensin‐receptor/neprilysin inhibitor (ARNI) sacubitril/valsartan reduces hospitalization and mortality for patients with heart failure with reduced ejection fraction. However, adoption of ARNI into clinical practice has been slow. Factors influencing use of ARNI have not been fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Nancy, Lippmann, Steven J., Mentz, Robert J., Greiner, Melissa A., Hammill, Bradley G., Hardy, N. Chantelle, Laskey, Warren K., Heidenreich, Paul A., Chang, Chun‐Lan, Hernandez, Adrian F., Curtis, Lesley H., Peterson, Pamela N., Fonarow, Gregg C., O'Brien, Emily C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405590/
https://www.ncbi.nlm.nih.gov/pubmed/30712431
http://dx.doi.org/10.1161/JAHA.118.010484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405590/
https://www.ncbi.nlm.nih.gov/pubmed/30712431
http://dx.doi.org/10.1161/JAHA.118.010484

Ejemplares similares